BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 26027508)

  • 1. Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis.
    Shimizu T; Takahata M; Kameda Y; Endo T; Hamano H; Hiratsuka S; Ota M; Iwasaki N
    Bone; 2015 Oct; 79():65-70. PubMed ID: 26027508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
    Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
    J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
    Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
    Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglec-15 on Osteoclasts Is Crucial for Bone Erosion in Serum-Transfer Arthritis.
    Korn MA; Schmitt H; Angermüller S; Chambers D; Seeling M; Lux UT; Brey S; Royzman D; Brückner C; Popp V; Percivalle E; Bäuerle T; Zinser E; Winkler TH; Steinkasserer A; Nimmerjahn F; Nitschke L
    J Immunol; 2020 Nov; 205(10):2595-2605. PubMed ID: 33020147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
    van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
    Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
    Cejka D; Hayer S; Niederreiter B; Sieghart W; Fuereder T; Zwerina J; Schett G
    Arthritis Rheum; 2010 Aug; 62(8):2294-302. PubMed ID: 20506288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fcγ receptor-mediated influx of S100A8/A9-producing neutrophils as inducer of bone erosion during antigen-induced arthritis.
    Di Ceglie I; Ascone G; Cremers NAJ; Sloetjes AW; Walgreen B; Vogl T; Roth J; Verbeek JS; van de Loo FAJ; Koenders MI; van der Kraan PM; Blom AB; van den Bosch MHJ; van Lent PLEM
    Arthritis Res Ther; 2018 May; 20(1):80. PubMed ID: 29720243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.
    Kato G; Shimizu Y; Arai Y; Suzuki N; Sugamori Y; Maeda M; Takahashi M; Tamura Y; Wakabayashi N; Murali R; Ono T; Ohya K; Mise-Omata S; Aoki K
    Arthritis Res Ther; 2015 Sep; 17(1):251. PubMed ID: 26373710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired signaling through the Fms-like tyrosine kinase 3 receptor increases osteoclast formation and bone damage in arthritis.
    Svensson MN; Erlandsson MC; Jonsson IM; Andersson KM; Bokarewa MI
    J Leukoc Biol; 2016 Mar; 99(3):413-23. PubMed ID: 26392589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Siglec-15 in regulating RAP1/RAC signaling in cytoskeletal remodeling in osteoclasts mediated by macrophage colony-stimulating factor.
    Kobayashi H; Terkawi MA; Ota M; Hasegawa T; Yamamoto T; Shimizu T; Sato D; Fujita R; Murakami T; Amizuka N; Iwasaki N; Takahata M
    Bone Res; 2024 Jun; 12(1):35. PubMed ID: 38849345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice.
    Hiruma Y; Tsuda E; Maeda N; Okada A; Kabasawa N; Miyamoto M; Hattori H; Fukuda C
    Bone; 2013 Mar; 53(1):87-93. PubMed ID: 23238125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation.
    Hiruma Y; Hirai T; Tsuda E
    Biochem Biophys Res Commun; 2011 Jun; 409(3):424-9. PubMed ID: 21586272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.
    Ishizuka Y; Moriwaki S; Kawahara-Hanaoka M; Uemura Y; Serizawa I; Miyauchi M; Shibata S; Kanaya T; Takata T; Taniguchi N; Niida S
    J Bone Miner Res; 2007 Dec; 22(12):1933-42. PubMed ID: 17680722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
    Humphrey MB; Nakamura MC
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):48-58. PubMed ID: 26573914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High LDL levels lessen bone destruction during antigen-induced arthritis by inhibiting osteoclast formation and function.
    Ascone G; Di Ceglie I; Walgreen B; Sloetjes AW; Lindhout E; Bot I; van de Loo FAJ; Koenders MI; van der Kraan PM; Blom AB; van den Bosch MHJ; van Lent PLEM
    Bone; 2020 Jan; 130():115140. PubMed ID: 31712132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice.
    Mukai T; Gallant R; Ishida S; Kittaka M; Yoshitaka T; Fox DA; Morita Y; Nishida K; Rottapel R; Ueki Y
    Arthritis Rheumatol; 2015 Mar; 67(3):656-67. PubMed ID: 25470448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12 kDa (DAP12).
    Ishida-Kitagawa N; Tanaka K; Bao X; Kimura T; Miura T; Kitaoka Y; Hayashi K; Sato M; Maruoka M; Ogawa T; Miyoshi J; Takeya T
    J Biol Chem; 2012 May; 287(21):17493-17502. PubMed ID: 22451653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast-like cells in murine collagen induced arthritis.
    Suzuki Y; Nishikaku F; Nakatuka M; Koga Y
    J Rheumatol; 1998 Jun; 25(6):1154-60. PubMed ID: 9632079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.